Contact
Please use this form to send email to PR contact of this press release:
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
TO:
Please use this form to send email to PR contact of this press release:
Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
TO: